Good Medicine: Europe Set for $4 Billion of Investments in Second-Quarter 2017 Science Capital/MRO Project Starts

SUGAR LAND--April 4, 2017--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Much like its North American brethren, the European Pharmaceutical & Biotech Industry, better described as the Life Science Industry, includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Continuing to return a healthy capital expenditure investment profile, Europe's volume of project activity continues to impress.